up nearly 4% bristol-myers gave you lots of smaller good ones.ut excellent preliminary revenue goals for new products including at least three new drugs they think could hit $4 billion in sales this deca decade that was exactly what we needed to hear because bristol-myers has a fabulous pipeline, bulked up by the acquisition of cellgreen and recently miocardia. the next few years, they simply use that money to pay down debt and roll out a $2 billion buyback. for years the stock has struggled to break out from its ceiling of resistance in the mid 60s where it's trading right now. i think it's way too cheap could this be what puts them over the edge? let's take a closer look with dr. giovanni caforio, chairman and ceo of bristol-myers squibb, to get a clear read on the vision of the future dr. caforio, welcome back to "mad money." >> thank you, jim. thanks for having me. >> okay. so, giovonni, i look through everything on miocardia and the acquisition and i started thinking, bear with me, all the things that it does are all the things that happen t

caforio: the last year has been important for bristol-myers squibb.blished a strong foundation for the company. today we have strong businesses and we are launching many new medicines. one of the things i discussed is the acceleration of the renewal of our portfolio with new medicines representing up to 30% of the company by 2025. at the same time, we have been clear that business development and acquisitions represent an important part of our strategy, which will come with our internal r&d efforts. last year we disclosed an important deal that gave us access to an innovative medicine. we highlighted our potential for the medicine yesterday. above $4 billion for that asset alone. going forward, cs continuing to invest -- i see us continuing to invest -- acquisitions are an important part of our strategy and we have the resources to act when we see an asset that is interesting for us. going to be not that wast the cbr associated with celegene. that was $6 billion? you backed the 2 billion buyback. our buybacks more important or do you think m&a is more

-- >> avy or bristol myers is better than merck. i think it's clear they're doing better than merck. they have a lot of things going for them and that's just the way it is. by the way, you know what i should have added here, bed, bath and beyond. that's another in the short. price target, bed bath and beyond 23 goes to 30 i, too, could play the role of an analyst this is the world of the bull market where price targets propel stocks higher so you know what just go with the flow. on "mad money" tonight, with americans banned from trading so many companies, i'm investigating what it looks like and looking for a prime time to buy, i won't even tell you, i'm going off the charts to find if the stock can continue to work higher now that everyone is pronounced it dead and i'm going to sit down with the ceo of car auction services to see if this boom in the used car more keark collide with digitization and make you money. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter have a question, tweet cramer #madtweets

approved in time >> a manufacturing issue and the analysts right now have not been in favor of bristol myersion involving. and they're not part of operation warp speed and they're kind of just right now in a holding pattern, disappointing versus the others even though i always revered the company and think that it is worth more. here's your 3% yield >> the other deal, jim, of course, is centene >> michael >> you know when we come back we'll have the ce, of centene. first, though, let's get to the bond report and give you a quick take on how charts are looking right now as we kick off the new year there's a look at yields across the board. ten-year 0.943 as we await construction spending data due out at the top of the hour and we should point out the yield on that ten-year note coming off the biggest one year decline since 2011 let's look at the dollars we finish up here lowest level since april of 2018 that was also an important story you could see what the year of last year at least looked like we'll see if that continues in this year's trading. we're back right after this. ed . the moment

. >> there are a lot of people who thought after the myocardial buy, celgene, bristol myers was going to go on a spree, the negative rap, like the negative rap by salesforce this morning, i think that gee vanny, it show with the buyback, they're generating a lot of cash with the anti-cancer franchise and eloquist and i watch football, and i say, that's bristol myers, and she says so what, and i say no, no, this is important. and i think she's right, the became is worth focusing on more than the ads back to you, carl. >> oh, my gosh, the browns first post season win on the road since '69 is that amazing? >> oh, my. and only up by 12. and i think the whole country was right at that moment saying it's going to happen again, el-foldo, and it didn't. carl, i thought that was one of the most exciting games i've seen >> unbelievable. congratulations to the folks in cleveland. so we're obviously off of what the pre-markets suggested, dow down 163 let's get to bob pisani. >> 4-1 declining to advancing stocks. take a look at the sector. it's the cyclical groups that have been doing so well that

here is the real issue innovation they classically don't have it look at lily, look at bristol myers.re the ones we're focussing on. >>> these go-to stocks i'm looking at have been crushing it since we found out about the vac seep -- vaccine because they do best when the economy is open of all the names i can find, they aren't done there is much more "mad money" ahead as the home trend continues, could logictech remain a winner? i'll talk with the ceo there is bank earnings calls and i'll reveal them to you and of course, all your calls, rapid fire in tonight's edition of the lightning round. so stay with cramer. (announcer) carvana's had a lot of firsts. 100% online car buying. car vending machines. and now, putting you in control of your financing. at carvana, get personalized terms, browse for cars that fit your budget, then customize your down payment and monthly payment. and these aren't made-up numbers. it's what you'll really pay, right down to the penny. whether you're shopping or just looking. it only takes a few seconds, and it won't affect your credit score. finally! a tota

holdings included, abvy and general mills, cat, bristol-myers.k to me >> yes so scott, i know jenny can relate to this very well what the clients are looking for. we had clients come to us and say we really want to get yield and we want to have exposure to the market so what we started looking at is how can we construct a portfolio to meat those needs because as you know, you can't get yield from fixed income and as they start to generate that income we said let's put together a quality and the quality is around profitability, and so we really look at those companies that are profitable and also companies that have a long, stable earnings where they can cover that dividend. and so we're looking at about a 4%, 5% yield and those are the companies in the overall portfolio to really meet that client that has that income requirement, but with a quality and also lower volatility to the general market >> okay. good stuff good for you up next, we'll hit those three big calls on ford, disney and walmart. we may also hear from the new national economic co

but listen, bristol myers i thought was ridiculous when he tried to stop that deal.has he done the stock's almost doubled i regard that as positive. they have done well, a little tracking, but they've done well, and weathered two of the worst ag years on record and when i went over fmc, which is the comp, and they preannounced a really bad number. fmc is the comp. that's the comp. and i regard that as being what we should be, what they should be shooting for. and fmc is a 7% organic, and collins has a 1% below, that but i don't know, i think that there's a lot of other guys to pit, david, other than jim look, collins is good. he's good to great >> jim collins of the author that you're referring to but yes. >> i wish jeff would pick on someone else. >> and we'll see shareholders have a voice here to decide that >> i like his numbers. >> they have gone through a lot of direction >> the numbers put together is very good. >> when starboard moves as we remember from the darden, when it was unusual, of course, when they took over the entire board. >> and it worked out fair

david, they're not buying bristol-myers.ying cciv and qs. >> don't want to pin yourself on those. >> carl, a couple things i want to hit in deal land. one that's not happening and another that did this morning involving lasers but first mgm, we talked about this last week they mgm, sports betting we talked about the growth here andover seas mgm says -- they walk away in the uk, you have to tell everybody everything there's no negotiation or not a lot that happens outside the light of day of a press release. they say after careful reflection regarding mgm's all stock rejected proposal and exchange rate of .6, it does not intend to submit a revised proposal and will not make a firm offer for entain. the price expectations that. went up to 13 bnt 5. what i hear is they're disciplined buyers and these guys had price expectations that were higher than had been perhaps anticipated. it doesn't mean the deal won't get done down the road they have a joint venture which acts as a poison pill for mgm. no other bidder. it's either mgm o

catch bristol-myers squibb ceo on "mad money.d we're right back after this. >>> coming up citigroup will la out with us, three trends to watch in 2021. stay tedun you're watching "squawk box" on cnbc cyber attacks are relentlessly advancing. to end them, cybereason built a cyber security solution so advanced... it can end attacks today -- on computers, mobile devices, servers and the cloud. and deliver future-ready protection, keeping you sharp for tomorrow. join us, the defenders, in our mission. cybereason. end cyber attacks. from endpoints to everywhere. >>> welcome back, everybody. all the major averages are looking at nice gains for the week and that say bit of an understatement that keeps setting new highs. joining us right now is david bailen, chief investment officer at citi private bank you're long in a lot of different areas. everything from the emerging markets to what you've been looking at with the cyclicals globally you like dividend paying stocks and this is the one that really caught my attention. you like reits,